Patients on hemodialysis who use opioids concurrently with a short-acting benzodiazepine are especially at risk for early death, a study found.
Clinicians should weigh the benefits and risks of renin-angiotensin-aldosterone-system inhibitors and diuretics, according to investigators.
In a real-world study, 3% of AKI events potentially related to use of immune checkpoint inhibitor therapy — a higher rate than reported in clinical trials.
Newly released safety data also show that roxadustat is associated with reduced cardiovascular risks compared with epoetin alfa.
In the TITAN trial, health-related quality of life did not worsen with the addition of apalutamide to ADT versus placebo for patients with metastatic castration-sensitive prostate cancer.
In a study, fathers who used intra-cytoplasmic sperm injection or in vitro fertilization had higher risk for prostate cancer than men who conceived naturally.